In regards to oncocytic variant of follicular thyroid carcinoma, (AKA Hurthle cell carcinoma), this is
a potentially extremely aggressive tumor and has, in a number of patients, been responsible for their deaths. It is not uncommon that I am sent patients with their Hurthle cell thyroid cancers widely metastatic throughout their body, yet their original tumor pathology had been characterized as "minimally invasive". The minimal standard of care for such tumors is to have a TOTAL thyroidectomy, followed by appropriate and diligent radioiodine ablation and long-term followup scanning, in addition to thyroglobulin assessments and anatomical imaging at appropriate intervals (see message #2552).
************ **PLEASE BE ADVISED***** ********* *******
THE INFORMATION CONTAINED IN THIS COMMUNICATION IS INTENDED FOR EDUCATIONAL PURPOSES ONLY. IT IS NOT INTENDED, NOR SHOULD IT BE CONSTRUED, AS SPECIFIC MEDICAL ADVICE OR DIRECTIONS. ANY PERSON VIEWING THIS INFORMATION IS ADVISED TO CONSULT THEIR OWN PHYSICIAN(S) ABOUT ANY MATTER REGARDING THEIR MEDICAL CARE.
************ ********* ********* ********* *********
Kenneth B. Ain, M.D.Professor of Medicine & The Carmen L. Buck Chair of Oncology ResearchDirector, Thyroid Oncology ProgramDivision of Endocrinology & Molecular MedicineDepartment of Internal Medicine, Room CC448University of Kentucky Medical Center, 800 Rose Street, Lexington, KY 40536-0093& Director, Thyroid Cancer Research Lab., Veterans Affairs Med. Cntr, Lexington, KY
'''''''''''' ''''''''' ''''''''' ''''''''' ''''''''' ''''''''' ''''''''' ''''''''